Drug Shortage Report for PMS-PREGABALIN
| Report ID | 39543 |
| Drug Identification Number | 02359618 |
| Brand name | PMS-PREGABALIN |
| Common or Proper name | PREGABALIN |
| Company Name | PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PREGABALIN |
| Strength(s) | 50MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-04-24 |
| Actual start date | |
| Estimated end date | 2018-06-10 |
| Actual end date | 2018-04-17 |
| Shortage status | Avoided shortage |
| Updated date | 2018-04-19 |
| Company comments | Avoided Shortage |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2018-04-19 | French | Compare |
| v6 | 2018-04-19 | French | Compare |
| v5 | 2018-04-19 | English | Compare |
| v4 | 2018-04-19 | French | Compare |
| v3 | 2018-04-19 | English | Compare |
| v2 | 2018-02-12 | French | Compare |
| v1 | 2018-02-12 | English | Compare |
Showing 1 to 7 of 7